PROSPECTS FOR INCREASING THE EFFICIENCY OF TREATMENT OF PATIENTS HEAVING OF LOCALLY- DISTRIBUTED BREAST CANCER
Improving the efficiency of treatment of locally distributed forms of breast cancer (BC) patients is relevant. The aim of the study: to determine the possibility of increasing the efficiency of treatment of patients with locally distributed BC by supplementing it with the determination of the exp...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Scientific Route OÜ
2020-05-01
|
Series: | EUREKA: Health Sciences |
Subjects: | |
Online Access: | http://journal.eu-jr.eu/health/article/view/1286 |
id |
doaj-6010f7176884419db3f2873425385a8b |
---|---|
record_format |
Article |
spelling |
doaj-6010f7176884419db3f2873425385a8b2020-11-25T03:13:11ZengScientific Route OÜEUREKA: Health Sciences2504-56602504-56792020-05-01361210.21303/2504-5679.2020.0012861286PROSPECTS FOR INCREASING THE EFFICIENCY OF TREATMENT OF PATIENTS HEAVING OF LOCALLY- DISTRIBUTED BREAST CANCERYuriy Vinnik0Yulia Belevtsova1Marina Sadchikova2Kharkiv Medical Academy of Postgraduate EducationKharkiv Medical Academy of Postgraduate EducationKharkiv Medical Academy of Postgraduate EducationImproving the efficiency of treatment of locally distributed forms of breast cancer (BC) patients is relevant. The aim of the study: to determine the possibility of increasing the efficiency of treatment of patients with locally distributed BC by supplementing it with the determination of the expression of TOP2 alpha and beta-tubulin III genes in the primary tumor during various chemotherapy regimens. Method. 139 patients with locally distributed BC were examined. Patients received 2-4 courses of neoadjuvant chemotherapy (NAChT) according to the TC (docetaxel + cyclophosphamide) and TAC (docetaxel + doxorubicin + cyclophosphamide) regimens, subsequent surgical intervention and 2–4 courses of AchT according to the FAC regimen. Immunohistochemical (IHCh) study of the levels of estrogen receptors (ER), progesterone (PR), epidermal growth factor (HER2) in tumors was conducted. The expression of TOP2 alpha and beta-tubulin class III genes was determined using PCR. Statistical data processing was performed using the program Stastistica for Windows 6. 0, Excel. Results. In the third cycle of chemotherapy, patients were transferred from the TC scheme to the TAC scheme. The frequency of the FPR increased 4 times in the group of patients with a triple negative tumor subtype compared with patients with luminal B. A combination of low expression of the class III beta-tubulin gene with high expression of TOP2 alpha in tumor tissue was found in 64.5 % of patients treated according to the TAC + cross over regimen and in 56.3 % of cases according to the TC regimen. A change in the receptor status of MLN after NAChT was detected in some cases. Conclusions. The combination of high expression of TOP2 alpha with low expression of class III beta-tubulins can be considered as a predictive sign of full pathomorphological response when using taxane-containing locally distributed BC. These markers can be recommended for determination in MLN (along with definition of ER, PR, HER2) in order to increase the effectiveness of AchT.http://journal.eu-jr.eu/health/article/view/1286locally distributed breast cancer; chemotherapy; estrogen; progesterone receptors; her2; lymph nodes; topoisomerase ii alpha; beta-tubulin iii |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yuriy Vinnik Yulia Belevtsova Marina Sadchikova |
spellingShingle |
Yuriy Vinnik Yulia Belevtsova Marina Sadchikova PROSPECTS FOR INCREASING THE EFFICIENCY OF TREATMENT OF PATIENTS HEAVING OF LOCALLY- DISTRIBUTED BREAST CANCER EUREKA: Health Sciences locally distributed breast cancer; chemotherapy; estrogen; progesterone receptors; her2; lymph nodes; topoisomerase ii alpha; beta-tubulin iii |
author_facet |
Yuriy Vinnik Yulia Belevtsova Marina Sadchikova |
author_sort |
Yuriy Vinnik |
title |
PROSPECTS FOR INCREASING THE EFFICIENCY OF TREATMENT OF PATIENTS HEAVING OF LOCALLY- DISTRIBUTED BREAST CANCER |
title_short |
PROSPECTS FOR INCREASING THE EFFICIENCY OF TREATMENT OF PATIENTS HEAVING OF LOCALLY- DISTRIBUTED BREAST CANCER |
title_full |
PROSPECTS FOR INCREASING THE EFFICIENCY OF TREATMENT OF PATIENTS HEAVING OF LOCALLY- DISTRIBUTED BREAST CANCER |
title_fullStr |
PROSPECTS FOR INCREASING THE EFFICIENCY OF TREATMENT OF PATIENTS HEAVING OF LOCALLY- DISTRIBUTED BREAST CANCER |
title_full_unstemmed |
PROSPECTS FOR INCREASING THE EFFICIENCY OF TREATMENT OF PATIENTS HEAVING OF LOCALLY- DISTRIBUTED BREAST CANCER |
title_sort |
prospects for increasing the efficiency of treatment of patients heaving of locally- distributed breast cancer |
publisher |
Scientific Route OÜ |
series |
EUREKA: Health Sciences |
issn |
2504-5660 2504-5679 |
publishDate |
2020-05-01 |
description |
Improving the efficiency of treatment of locally distributed forms of breast cancer (BC) patients is relevant.
The aim of the study: to determine the possibility of increasing the efficiency of treatment of patients with locally distributed BC by supplementing it with the determination of the expression of TOP2 alpha and beta-tubulin III genes in the primary tumor during various chemotherapy regimens.
Method. 139 patients with locally distributed BC were examined. Patients received 2-4 courses of neoadjuvant chemotherapy (NAChT) according to the TC (docetaxel + cyclophosphamide) and TAC (docetaxel + doxorubicin + cyclophosphamide) regimens, subsequent surgical intervention and 2–4 courses of AchT according to the FAC regimen. Immunohistochemical (IHCh) study of the levels of estrogen receptors (ER), progesterone (PR), epidermal growth factor (HER2) in tumors was conducted. The expression of TOP2 alpha and beta-tubulin class III genes was determined using PCR. Statistical data processing was performed using the program Stastistica for Windows 6. 0, Excel.
Results. In the third cycle of chemotherapy, patients were transferred from the TC scheme to the TAC scheme. The frequency of the FPR increased 4 times in the group of patients with a triple negative tumor subtype compared with patients with luminal B. A combination of low expression of the class III beta-tubulin gene with high expression of TOP2 alpha in tumor tissue was found in 64.5 % of patients treated according to the TAC + cross over regimen and in 56.3 % of cases according to the TC regimen. A change in the receptor status of MLN after NAChT was detected in some cases.
Conclusions. The combination of high expression of TOP2 alpha with low expression of class III beta-tubulins can be considered as a predictive sign of full pathomorphological response when using taxane-containing locally distributed BC. These markers can be recommended for determination in MLN (along with definition of ER, PR, HER2) in order to increase the effectiveness of AchT. |
topic |
locally distributed breast cancer; chemotherapy; estrogen; progesterone receptors; her2; lymph nodes; topoisomerase ii alpha; beta-tubulin iii |
url |
http://journal.eu-jr.eu/health/article/view/1286 |
work_keys_str_mv |
AT yuriyvinnik prospectsforincreasingtheefficiencyoftreatmentofpatientsheavingoflocallydistributedbreastcancer AT yuliabelevtsova prospectsforincreasingtheefficiencyoftreatmentofpatientsheavingoflocallydistributedbreastcancer AT marinasadchikova prospectsforincreasingtheefficiencyoftreatmentofpatientsheavingoflocallydistributedbreastcancer |
_version_ |
1724648254696587264 |